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CORONARY ARTERY BYPASS GRAFT ING (CABG ) REMAINS A F IRST -L INE
TREATMENT FOR CORONARY ARTERY DI SEASE , with good long-term clinical
outcomes. Although left internal mammary grafts have high long-term patency rates, in current CABG
practice the overwhelming majority of patients also require saphenous vein grafts (SVG) as bypass
conduits. SVG occlusion following surgery remains a signiﬁcant limitation of CABG. Serial angiographic
follow-up studies demonstrate that approximately 10% of SVG occlude in the ﬁrst year after which there
is a continued attrition which accelerates as grafts age. However, the relationship between angio-
graphic stenosis and SVG occlusion is less clear, since the majority of graft occlusions occur in grafts
previously characterized as angiographically normal (1).
We performed elective angiography (n  42) with optical coherence tomography (OCT) (n  16) and
ntravascular ultrasound (IVUS) (n  21) assessment of patent SVG in asymptomatic patients 3 years
after surgery. All aspects of the study were approved by local and national ethical committee. Patients
gave written informed consent prior to the procedure. Fifty-ﬁve percent of SVGs were occluded
(patency rates: 93% left internal mammary artery, 73% right internal mammary artery, 36% radial
conduit patency). All patent grafts imaged had variable ﬁbrocellular neointima but no signiﬁcant
stenotic disease. OCT but not IVUS demonstrated ﬁndings consistent with thin-cap ﬁbroatheroma (2) in
6 of 16 SVGs and luminal adherent thrombus in 4 of 16 SVGs. These novel features may be important
markers of vein grafts vulnerable to future occlusion.
This analysis of SVGs assessed by angiography and endoluminal imaging with IVUS and OCT suggests
that following contemporary surgery with appropriate concomitant secondary prevention therapy
there remains signiﬁcant loss of SVG conduits following CABG but with little development of stenotic
disease in patent vein grafts after 3 years. OCT, but not IVUS, identiﬁes clear features of atherosclerosis,
including circumferential ﬁbrous neointima, thin cap ﬁbroatheroma, and adherent thrombus. Our
ﬁndings suggest that high resolution imaging techniques such as OCT may begin to allow us insights
into the causes of vein graft failure (Figs. 1, 2, and 3)
From the Department of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
This work was supported by the NIHR Biomedical Research Centre, Oxford, and by grants from the British Heart Foundation
(RG/02/006 to K.M.C., FS/03/105/16340 to C.S. PG/05/040 and FS/06/024 to P.L.) and a Marie Curie Re-Integration
Grant, within the 7th European Community Framework Programme (to C.A.). All authors have reported that they have no
relationships to disclose.
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 4 , N O . 7 , 2 0 1 1
J U L Y 2 0 1 1 : 8 0 7 – 9
Adlam et al.
IVUS and OCT of Saphenous Vein Grafts
808Figure 1. Neointima in Example SVG Shown Angiographically and With OCT and IVUS
Example images by optical coherence tomography (OCT) (A to D) and intravascular ultrasound (IVUS) (E to H) from saphenous vein grafts (SVGs) shown angio-
graphically (I to L) for the same 4 patients. Typical ﬁndings were of a double layered appearance of the vein graft vessel wall due to neointima formation within
the original vein graft wall. Neointimal thickness varied both between patients and within different segments and sectors of the grafts.Figure 2. Vein Graft Atherosclerosis
Areas of thin-cap ﬁbroatheroma (TCFA) identiﬁed by OCT (A to D) characterized by a thin bright cap at the luminal surface of the SVG vessel wall with efface-
ment of usual deﬁned features deeper in the vessel wall. This OCT feature has been described in native coronary arteries and correlated histologically with the
TCFA overlying a lipid rich plaque and may be particularly associated with plaque of high macrophage content (2). OCT features of TCFA were identiﬁed in 6 of
16 SVGs assessed with 3 SVGs extensively affected and 3 showing isolated plaques only. Examples affecting either local segments (A, D) or almost concentric
involvement (B) are shown. IVUS images from the same segments of the same SVGs do not show a clear deﬁnable abnormality (E to H). Angiographically (I to L) SVGs
showed only minor irregularity without signiﬁcant stenotic disease and no speciﬁc features at the site of TCFA on OCT (arrows). Abbreviations as in Figure 1.
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Figure 3. Luminal Adherent Thrombus
Bright free ﬂoating densities attached to the luminal surface are demonstrated from 4 different SVGs (A to D). These cast an optical shadow on deeper struc-
tures of the vessel wall and appear consistent with luminal thrombus. All patients were taking Aspirin. No IVUS or angiographic abnormalities were seen in the
corresponding segments of the SVG imaged by these modalities. Abbreviations as in Figure 1.2R E F E R E N C E S
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